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684Objective:Atrial septal defect (ASD) is a common congenital heart disease (CHD). Althoughmost cases are spo-
radic, familial cases have been reported. The transcription factors NKX2.5 and GATA4 play important roles in the
pathogenesis of ASD. Mutations in either gene have been identified in familial cases of ASD. Here, we examine
a Chinese family with isolated ASD to find out whether there is any mutation in NKX2.5 or GATA4 accounting
for the etiology.
Methods:We identified kindred spanning 3 generations in which 8 of 31 (38%) individuals had ASD. One hun-
dred seventy unrelated individuals were included as controls. Peripheral blood samples were collected and geno-
mic DNA was extracted from the leukocytes. NKX2.5 and GATA4 were amplified by polymerase chain reaction
(PCR) with specific primers. The sequences of PCR products were compared between affected members and
unaffected members, as well as controls.
Results: Direct sequencing of NKX2.5 from the genomic DNA of family members failed to identify mutations,
whereas sequencing of GATA4 identified an A-to-G transition at nucleotide 928 in exon 5 that predicted a methi-
onine to valine substitution at codon 310 (M310V) in the NLS region. All affected members and a patriarch of the
family who was recognized as a carrier exhibited this mutation, whereas the other unaffected family members or
control individuals did not. This mutation has not been reported previously in either familial or sporadic cases of
CHD.
Conclusions:We identified a novel M310V mutation in GATA4 gene that is located in the NLS region and leads
to hereditary ASD in a Chinese family. In this family, we identified a carrier with incomplete penetrance and
8 patients with variable expressivity. However, the mechanism by which this mutation contributes to the devel-
opment of a congenital heart defect remains to be ascertained. (J Thorac Cardiovasc Surg 2010;140:684-7)Atrial septal defect is a common congenital heart disease,
and although most cases are sporadic, familial cases have
been reported. The transcription factors NKX2.5 and
GATA4 play important roles in the pathogenesis of atrial
septal defect. Mutations in the NKX2.5 gene have been iden-
tified in familial cases of atrial septal defect with atrioven-
tricular conduction abnormalities, and mutations in GATA4
have been found in familial cases of isolated atrial septal
defect. Here, we present 8 cases from a large Chinese family
with 3 generations of isolated atrial septal defect. Disease
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The Journal of Thoracic and Cardiovascular Surgsomal dominant mode of inheritance. A novel heterozygous
M310V missense mutation in the nuclear localization signal
region of exon 5 of GATA4 was detected in all investigated
patients with atrial septal defect in this family. The mutation
was also found in a patriarch of the family who was recog-
nized as a carrier, but it was not seen in other unaffected
family members or any control individuals.
Atrial septal defect (ASD) is a common form of congen-
ital heart disease (CHD), and the prevalence of familial ASD
is significantly higher than that of other familial CHDs.
Recently, both the genetic basis of familial ASD and the
role of transcription factors as mediators of cardiac morpho-
genesis have been investigated.1-3 Genetic factors have
been found to play a predominant role in the pathogenesis
of familial ASD, and heterozygous mutations in 2
transcription factor genes, NKX2.5 (or CSX) and GATA4,
have been identified as causative factors of familial ASD.4-6
Mutations in NKX2.5 have been detected in families with
inherited autosomal dominant ASD (secundum type) with
atrioventricular conduction block,6-8 whereas mutations in
GATA4 are more likely to be associated with cardiac
malformations thanwithdisturbances in the conduction system.
GATA4, which encodes a zinc-finger transcription factor,
is essential for endodermal differentiation and ventralery c September 2010
TABLE 1. CHD types and need for surgical repair
Patient ID CHD Surgery required
II-3 ASD þ
II-4 ASD þ
II-6 ASDþPS þ
II-7 ASD 
III-3 ASDþPS þ
III-4 ASDþPS þ
III-5 ASD þ
III-7 ASD 
CHD, Congenital heart disease; ASD, atrial septal defect; PS, pulmonary stenosis. II-3,
III-3, and III-4 underwent surgery previously.
Abbreviations and Acronyms
ASD ¼ atrial septal defect
CHD ¼ congenital heart disease
CZf ¼ C-terminal zinc finger
NLS ¼ nuclear localization signal
NZf ¼ N-terminal zinc finger
Chen et al Evolving Technology/Basic Sciencemorphogenesis.9-12 The GATA4 protein binds the GATA
motif consensus sequence to modulate the transcription of
target genes.13 GATA4 has 442 amino acids with two trans-
activation domains; two zinc fingers, one at the N-terminus
(NZf) and the other at the C-terminus (CZf); and a nuclear
localization signal (NLS), for import into the nucleus. The
CZf and the adjacent basic domain of GATA4 have dual
functions in both DNA binding and nuclear localization.14
The amino acids 270–324 fragment within the DNA-
binding domain at amino acids 216–324 has been identified
as the minimal, functional NLS region for actively transport-
ing GATA4 into the nucleus of both HeLa cells and cardiac
myocytes.15
We identified a large Chinese family with familial ASD
after performing surgical repairs on a mother and 2 daugh-
ters who had the same congenital ASD. To identify the
genetic basis for the familial ASD in this family, we con-
ducted a clinical and genetic analysis, diagnosing a total of
8 family members with congenital ASD (secundum type).
A novel missense mutation of GATA4 was found in the
NLS region. A patriarch with this mutation did not have
ASD but was found to be a carrier. The 8 pedigree members
with complete penetrance strongly suggest that, in this
family, ASD may be caused by a single-gene defect and
dominantly inherited.
PATIENTS AND METHODS
Study Population
We identified a large kindred spanning 3 generations, in which 8 individ-
uals had ASD (secundum type) (II-3, II-4, II-6, II-7, III-3, III-4, III-5, III-7;FIGURE 1. Pedigree of a large Chinese family with heart defects. Participatin
septal defect (ASD) was observed in 8 members and pulmonary stenosis (PS) in
The Journal of Thoracic and CaFigure 1); the incidence of ASD in the members surveyed was 38% (8/21).
Clinical manifestations were varied, with 6 patients (II-3, II-4, II-6, III-3,
III-4, III-5) requiring surgical repair and 3 (II-6, III-3, III-4) who had pulmo-
nary stenosis in addition to ASD (Table 1). In all cases, the diagnosis was
made by a cardiologist and a cardiac surgeon on the basis of medical and
surgical histories, physical signs, 12-lead electrocardiograms, and color
Doppler echocardiograms. The patent foramen ovale was excluded. The
cardiac conduction system and the other organs were unaffected in the pa-
tients with ASD, suggesting that CHD in this family was isolated, without
syndromic disease. As controls, we included 170 unrelated individuals, 100
of whom were healthy and 70 of whom had various forms of sporadic
CHDs, including 20 cases of ASD. Informed consent was obtained from
each participant, and the research protocols and procedures were approved
by the Institutional Research Ethics Committee of Peking University Peo-
ple’s Hospital. Peripheral blood samples were collected and DNA was ex-
tracted from the leukocytes.Genetic Analysis
Exons 2 to 7 of GATA4 (accession No. NM_002052) and exons 1 to 2 of
NKX2.5 (NM_004387) were amplified by polymerase chain reaction with
specific primers, as described previously.5,16 Genomic DNA (50 ng) was
amplified in a 50-mL reaction. The touchdown polymerase chain reaction
program for GATA4 was 5 minutes at 94C, 35 cycles of 30 seconds at
94C, 30 seconds at 58C to 53C (touchdown temperature of 53C),
1 minute at 72C, and 5 minutes at 72C. Amplification of NKX2.5 was
5 minutes at 94C, 35 cycles of 45 seconds at 94C, 30 seconds at 63C
to 58C (touchdown temperature of 58C), 45 seconds at 72C, and
5 minutes at 72C. Products were run on 1% agarose gels to verify
amplification, and purified products were sequenced in the sense direction
with an ABI 3730XL DNA Analyzer (Applied Biosystems, Inc, Foster
City, Calif) by SinoGenoMax Co (Beijing, China).g members of each generation are indicated numerically. Secundum atrial
3.
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FIGURE 2. All members with the heart defects as well as the individual I-1 had a GATA4 mutation, an A-to-G transition at nucleotide 928 in exon 5 of
GATA4. Other unaffected family members with wild type alleles of GATA4 (top) and an unaffected member hererozygous for a mutated allele (bottom)
are shown. Wild type (WT) and mutated (MU) amino acid sequences of GATA4 protein. The A928G transition creates a methionine to valine substitution
at codone 310.
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Direct sequencing of NKX2.5 from the genomic DNA of
family members failed to identify mutations, ruling out
NKX2.5 as the genetic basis of ASD in this family. Direct se-
quencing of GATA4 identified an A-to-G transition at nucle-
otide 928 in exon 5 that predicted a methionine to valine
substitution at codon 310 (M310V) in the NLS region
(Figure 2). To the best of our knowledge, this mutation
has not been reported previously in either familial or spo-
radic cases of CHD. In fact, reports of mutations in the
GATA4 NLS region are rare. We therefore believe we
have identified a novel, CHD-associated mutation. All
affected members, including the family patriarch, exhibited
the M310V mutation, suggesting high penetrance of the dis-
ease phenotype. Absence of a clinical phenotype in the patri-
arch with the mutation showed this disease has incomplete
penetrance. This mutation was not found in the other unaf-
fected family members or in the 170 control individuals.
DISCUSSION
To date, only four mutations in GATA4 have been
reported to be associated with isolated ASD in unrelated
families.4,5,17 These mutations include one between theFIGURE 3. Conserved domains of GATA4 protein indicate transactivation dom
nuclear localization signal (NLS). The location of M310V is shown.
686 The Journal of Thoracic and Cardiovascular SurgCZf and the NLS (G296S), one missense mutation (S52F)
in transactivation domain 1, and two frameshift mutations,
1074 (delC) and 1075 (delG), in the C-terminal region.
Garg and associates4 reported that the G296S mutation
disrupts the DNA-binding and transactivation activity of
GATA4 and destroys the synergy in transcriptional activa-
tion between GATA4 and its cofactor TBX5, resulting in
heart anomalies such as pulmonary stenosis, atrioventricular
septal defect, aortic regurgitation, and patent ductus arterio-
sus, in addition to ASD.
Here, we present the first report of an M310V mutation in
the NLS region, which is necessary and sufficient for the nu-
clear localization that is required for GATA4 transcription
factor activity (Figure 3). This mutation affected a highly
conserved residue and was not detected in any of 170 unre-
lated control individuals. Mutations in GATA4 that change
the NLS might lead to reduced transcriptional activity by al-
tering the structure of the protein in a way that impairs im-
port into the nucleus, thereby affecting transcriptional
activation. M310V mutation is also immediately adjacent
to the CZf, which is essential for DNA-binding and interac-
tion with cofactors.14 Therefore, it may also disrupt the inter-
action between GATA4 and TBX5 or NKX2.5, which isains (TAD), N-terminal zinc finger (NZf), C-terminal zinc finger (CZf), and
ery c September 2010
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nary stenosis seen in 3 affected members of this family.
Although pedigree analysis (Figure 1) showed an autoso-
mal dominant trait with high penetrance in this family,
incomplete penetrance and variable expressivity accounted
for the diversity in clinical status in this family, whose mem-
bers varied in the presence of a clinical phenotype, surgical
requirements, and the presence of other defects.18 Individual
I-2 was clinically unaffected, even though he had theM310V
mutation. We explain his case with several assumptions.
First, incomplete penetrance is a common phenomenon in
autosomal dominant phenotypes. Heterozygotes with func-
tional haploinsufficiency who bear the gene mutation can
be free of clinical phenotype, leading to observations of ata-
vism in these families. Second, the diagnostic techniques
used in this study could have contributed to an underestima-
tion of the phenotype, especially in family members who did
not undergo surgery. Transthoracic echocardiography is the
only available objective diagnostic modality, but it is thought
to have lower sensitivity in identifying cardiac abnormalities
than do transesophageal echocardiography or magnetic reso-
nance imaging19,20; however, it is unlikely to have changed
the principal findings of this study. Finally, ASD is one of
several congenital malformations that can resolve
spontaneously,21,22 so that evaluations performed after
this event will show a reduced gene penetrance. Therefore,
in the absence of information on individual I-2’s predecessors,
we suggest that incomplete penetrance, inaccurate diagnosis,
and age-dependent phenotype explain his clinical status.
We plan to continue monitoring the members of this fam-
ily, including evaluation of additional siblings and off-
spring, particularly those of affected individuals, to
determine whether the ASD in this family is caused by
a single-gene defect.
In conclusion, we identified a novel M310V mutation in
GATA4 that is located in the NLS region and leads to hered-
itary ASD in a Chinese family. In this family, we identified
a carrier with incomplete penetrance and 8 patients with var-
iable expressivity. However, the mechanism by which this
mutation contributes to the development of a congenital
heart defect remains to be ascertained.
With the development of gene therapy and genomic strat-
egies for cardiovascular surgery, further investigation of
GATA4 mutations in humans with familial congenital heart
defects will provide new avenues for the prevention and
therapy of inherited cardiovascular diseases.23
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